TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT05700578

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Safety Behavior Elimination for Traumatic Stress (SBETS)
Description: This intervention took 30 minutes to complete. At the end of the intervention, participants were instructed to select two of their most commonly-used trauma-related safety behaviors to reduce or eliminate over the coming month.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Modifiable Behavior Intervention (MoBI)
Description: The intervention took 30 minutes to complete. At the end of the intervention, participants were instructed to select two of their most commonly-used unhealthy behaviors to reduce or eliminate over the coming month.
Study: NCT05652400

Intervention type: OTHER
Intervention: Exposure to antiretroviral therapy
Description: Outcomes will be compared with regard to current or previous exposure to antiretroviral therapy.
Study: NCT04772521

Intervention type: BEHAVIORAL
Group type: PLACEBO_COMPARATOR
Intervention: General health talk
Description: Health talk provided information about hazards of tobacco (active smoking, second- and third-hand smoke), benefits of quitting smoking and methods to quit smoking.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: General health talk
Description: Health talk provided information about hazards of tobacco (active smoking, second- and third-hand smoke), benefits of quitting smoking and methods to quit smoking.
Study: NCT06438692

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: VOM ethanol chemical ablation and 2C3L
Description: Annular pulmonary vein ablation, mitral isthmus line ablation, tricuspid isthmus line ablation, apex line ablation，anhydrous alcohol ablation of VOM

Intervention type: PROCEDURE
Group type: SHAM_COMPARATOR
Intervention: 2C3L
Description: Annular pulmonary vein ablation, mitral isthmus line ablation, tricuspid isthmus line ablation, apex line ablation
Study: NCT04772521

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Personalized chat-based interactions
Description: Individual chat-based interactions last 3 months and consist of 2 parts. First part is regular message. The schedule will be adjusted according to the participants' quitting and mental health status. The second part includes real-time psycho-behavioral intervention delivered by trained cessation counsellors using the acceptance and commitment therapy (ACT) model for smoking cessation and reliving mental health problems. The conversation is based on participants' socio-demographic characteristics, smoking habit at baseline, and updated smoking status and mental health status assessed during online conversation and the baseline questionnaire.

Intervention type: BEHAVIORAL
Group type: PLACEBO_COMPARATOR
Intervention: Text message
Description: Regular messages will be sent twice per month within 3 months. These messages covers simple cessation advice and reminders for follow-ups.

Intervention type: BEHAVIORAL
Group type: PLACEBO_COMPARATOR
Intervention: Phone follow-up/counselling service
Description: The intervention outcomes and participants' smoking status will be followed up regularly via telephone interviews (15 - 30 minutes).

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Phone follow-up/counselling service
Description: The intervention outcomes and participants' smoking status will be followed up regularly via telephone interviews (15 - 30 minutes).

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Mailed nicotine replacement therapy (NRT)
Description: Full course of NRT treatment (8 weeks) will be provided to all participants who are still smoking at 6-month follow-up and request, or willing to use NRT after advice from counsellors. Medications will be mailed from the smoking cessation clinics.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Mailed nicotine replacement therapy (NRT)
Description: Full course of NRT treatment (8 weeks) will be provided to all participants who are still smoking at 6-month follow-up and request, or willing to use NRT after advice from counsellors. Medications will be mailed from the smoking cessation clinics.
Study: NCT04928469

Intervention type: OTHER
Intervention: No intervention performed
Description: Collection of clinical and laboratory data

Intervention type: OTHER
Intervention: No intervention performed
Description: Collection of clinical and laboratory data
Study: NCT06449508

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Probiotic Formula
Description: drops of probiotic supplement containing bacillus clausil spores (Enterogermania Amp 2 Billion/5Ml )
Study: NCT06124586

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Percutaneous transluminal angioplasty
Description: Percutaneous transluminal angioplasty of the leg

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Percutaneous transluminal angioplasty
Description: Percutaneous transluminal angioplasty of the leg
Study: NCT06184906

Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Weaning by Mediterranean Diet
Description: Introduce solid foods typical of the Mediterranean Diet at weaning of infants

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Weaning by Mediterranean Diet
Description: Introduce solid foods typical of the Mediterranean Diet at weaning of infants
Study: NCT05061485

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Sucrose
Description: The participants consume A) water with 75 g sucrose

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Sucrose + protein
Description: The participants consume B) water with 75 g sucrose + approx. 100 kcal protein

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Sucrose + fat
Description: The participants C) water with 75 g sucrose + approx. 100 kcal fat
Study: NCT05974956

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Mastitis care teaching protocol
Description: It was developed by the authors based on previous similar studies, articles and library resources. It was introduced to the study group in the form of face to face sessions plus a hand out copy. It consisted of three parts; (1): Theoretical part about mastitis (definition, types, clinical manifestation, possible causes, diagnosis and management). (2):Self-care practices, and (3):Recommendations regarding dietary measures, rest, medication and follow up.
Study: NCT04781647

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ETV
Description: Participants will receive ETV 0.5 mg tablets orally once daily

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: ETV
Description: Participants will receive ETV 0.5 mg tablets orally once daily

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Peg-IFNα
Description: Participants will receive Peg-IFNα with a starting dose of 180 µg solution by subcutaneous injection once weekly

Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: Peg-IFNα
Description: Participants will receive Peg-IFNα with a starting dose of 180 µg solution by subcutaneous injection once weekly
Study: NCT06071520

Intervention type: DRUG
Intervention: Fostamatinib
Description: Patient treated with fostamatinib in the period described
Study: NCT05501769

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ARV-471 in combination with Everolimus
Description: ARV-471 oral tablets in combination with everolimus administered daily in 28 day cycles
Study: NCT05392387

Intervention type: OTHER
Intervention: Standard antiviral therapy
Description: pegylated interferon or/and nucleos(t)ide analogues

Intervention type: OTHER
Intervention: Standard antiviral therapy
Description: pegylated interferon or/and nucleos(t)ide analogues

Intervention type: OTHER
Intervention: Standard antiviral therapy
Description: pegylated interferon or/and nucleos(t)ide analogues
Study: NCT05888181

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Mobile app-based self-management intervention
Description: The self-management program, accessible via a smartphone app, comprises several components. First, the app contains an RA-specific educational program presented as videos in 16 weekly modules. Second, the app provides patients with tailored lifestyle advice, both as part of the educational program and in the form of personalized messages from a certified health coach. Third, the study app includes remote monitoring features underpinned by goal-setting principles. For instance, participants can use the app to log daily steps and physical activity, as well as their diet, sleep, and mental health. Personal goals, as well as physical challenges and meditation or mindfulness exercises, can be set up within the app to encourage behavioral change.~Finally, patient-reported disease burden can be monitored within the study app via the RAID instrument. Based on random allocation to one of both intervention groups, the RAID will be prompted either weekly (group A) or monthly (group B).

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Mobile app-based self-management intervention
Description: The self-management program, accessible via a smartphone app, comprises several components. First, the app contains an RA-specific educational program presented as videos in 16 weekly modules. Second, the app provides patients with tailored lifestyle advice, both as part of the educational program and in the form of personalized messages from a certified health coach. Third, the study app includes remote monitoring features underpinned by goal-setting principles. For instance, participants can use the app to log daily steps and physical activity, as well as their diet, sleep, and mental health. Personal goals, as well as physical challenges and meditation or mindfulness exercises, can be set up within the app to encourage behavioral change.~Finally, patient-reported disease burden can be monitored within the study app via the RAID instrument. Based on random allocation to one of both intervention groups, the RAID will be prompted either weekly (group A) or monthly (group B).
Study: NCT05476666

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Peripherial and central venous access
Description: Passing a peripherial and a central venous catheter/cannula
Study: NCT04904783

Intervention type: RADIATION
Group type: ACTIVE_COMPARATOR
Intervention: Low dose radiotherapy
Description: Patients in study group will receive LDRT to both lungs by two parallel opposed fields, antero-posterior (AP) and postero-anterior (PA) to deliver a midplane dose of 0.5 Gy in a single fraction. As this dose is very less, doses to the critical structures including heart and lungs would be very low. All the patients will be treated on Telecobalt unit (Theratronics Phoenix, Canada) and not on the linear accelerator to avoid risks to cancer patients on treatment with linear accelerator. CT based plan will not be undertaken for logistic issues and is also not felt to be mandatory for this LDRT. Dose computation would be carried out by manual dose calculation for the Telecobalt unit.
Study: NCT04758676

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Nutritional and physiotherapy protocol, BIA
Description: Study subjects will be treated using the nutritional and physiotherapy protocol, based upon the results of measurements, using bioimpedance analysis.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Standard of care
Description: Study subjects will receive the current standard of care.
Study: NCT06009172

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Auricular point acupressure (APA)
Description: Auricular point acupressure (APA) is a method derived from Traditional Chinese Medicine. PCOS women in the APA group began to apply pressure on the first day of enrollment. Patients were instructed to press each acupuncture point 3 times a day for 30 times. The PCOS woman is then trained to go to the outpatient clinic every 5-7 days to change the auricular acupressure sticker. The intervention period was 4 weeks.
Study: NCT05896111

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Physical therapy exercises.
Description: Exercises to treat hemiparetic cerebral palsy

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Physical therapy exercises.
Description: Exercises to treat hemiparetic cerebral palsy
Study: NCT05660330

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Holistic semi-tailormade well-being intervention
Description: The holistic well-being intervention consists of a mandatory basic package that will take 2 half days and 1 full day to complete. In the first half day, the conclusion of the baseline measurement will be discussed, as well as the specific outline of the well-being thay. On the well-being day, three trained professionals from an HR service company, called Liantis, will guide these interventions (consisting of training and workshops) in the workplace. Only a small proportion of the company employees, called the ambassadors, will attend the well-being day. In the second half day, the ambassadors will be coached to disseminate the obtained information to the entire workplace. This information will be personalized according to the problems, needs and context of each company. Besides the basic package, an optional expertise package will be offered during this second half day. In the period afterwards, the ambassadors are followed every 2 months by means of a semi-structured interview.
Study: NCT04757714

Intervention type: PROCEDURE
Group type: OTHER
Intervention: The high-resolution peripheral scanner (HRpQCT) of the tibia and radius
Description: The high-resolution peripheral scanner (HRpQCT) of the tibia and radius

Intervention type: PROCEDURE
Group type: OTHER
Intervention: a low-dose imaging system exploration of their thoraco-lumbar spine (EOS system)
Description: a low-dose imaging system exploration of their thoraco-lumbar spine (EOS system)

Intervention type: OTHER
Group type: OTHER
Intervention: Questionnaires
Description: * a physical activity questionnaire (PHAS instrument)~* a COPD quality of life questionnaire (St George Hospital)

Intervention type: OTHER
Group type: OTHER
Intervention: A search for sarcopenia by studying the strength of the grip (dynamometer)
Description: A search for sarcopenia by studying the strength of the grip (dynamometer)
Study: NCT05905133

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CBP-201
Description: subcutaneous injection
Study: NCT05721300

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: NAs（EntecavirorTenofovirorTenofovir alafenamide） combined with interferon treatments
Description: NAs（EntecavirorTenofovirorTenofovir alafenamide） combine with interferon treatments for 48 weeks, and then continue with NAs treatment（EntecavirorTenofovirorTenofovir alafenamide）

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: NAs （EntecavirorTenofovirorTenofovir alafenamide） treatments
Description: patients receive NAs（EntecavirorTenofovirorTenofovir alafenamide） treatment at least 48 weeks
Study: NCT04958759

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Functional Inspiratory Muscle Training
Description: The inspiratory muscle training program will be consist of 4 weeks of foundation inspiratory muscle training and 6 weeks of functional inspiratory muscle training

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Inspiratory Muscle Training
Description: The inspiratory muscle training program will be consist of 10 weeks of foundation inspiratory muscle training

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Inspiratory Muscle Training
Description: The inspiratory muscle training program will be consist of 10 weeks of foundation inspiratory muscle training

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Breathing exercises
Description: The program will be consist of 10 weeks of breathing exercises
Study: NCT06112795

Intervention type: OTHER
Intervention: Non-Interventional Study
Description: Non-interventional study
Study: NCT04709341

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: TR Band 60MIN
Description: TR-Band will be in left in place for 15 minutes before it is gradually deflated by 25% at 15 minute intervals

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: TR Band 120MIN
Description: TR-Band is left in place for 60 minutes before it is gradually deflated by 25% at 15 minute intervals
Study: NCT05105516

Intervention type: PROCEDURE
Group type: OTHER
Intervention: Ablation
Description: Ablation of ectopic foci causing PVCs
Study: NCT05133258

Intervention type: OTHER
Intervention: Aspiration of middle ear fluid following standard-of-care delivery of ciprofloxacin and dexamethasone suspension
Description: Micro-aspirate of middle ear fluid will be taken from participants with a Juhn Tym-Tap specimen trap following standard-of-care delivery of ciprofloxacin 0.3% and dexamethasone 0.1% suspension. Samples will be analyzed to measure antibiotic concentration in the middle ear fluid.
Study: NCT05870228

Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Strathclyde Sleep Intervention
Description: Manual-based CBT-I
Study: NCT05765448

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Soy control
Description: Soy isolate control meal

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Intervention (Laver/nori (Porphyra umbillicus) macroalgae whole biomass)
Description: Laver/nori (Porphyra umbillicus) macroalgae whole biomass treatment meal

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Intervention (Laver/nori macroalgae (Porphyra umbillicus) protein isolates)
Description: Laver/nori macroalgae (Porphyra umbillicus) protein isolates treatment meal

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Intervention (Chlorella microalgae (Chlorella vulgaris) whole biomass)
Description: Chlorella microalgae (Chlorella vulgaris) whole biomass treatment meal

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Intervention (Chlorella microalgae (Chlorella vulgaris) protein isolates)
Description: Chlorella microalgae (Chlorella vulgaris) protein isolates treatment meal
Study: NCT06199271

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Adebrelimab and dalpiciclib
Description: Before surgery, the eligible patients received 3 cycles of adebrelimab (1200 mg intravenously every 3 weeks, Day 1, 22 and 43) and 2 cycles of dalpiciclib (150 mg, po, every 4 weeks, day 1-21 and 29-49). Administration dose adjustments were permitted according to the haematological or non-haematological toxicity.
Study: NCT06229977

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Palmitoylethanolamide (PEA)
Description: Participants will receive PEA at a dose of 600mg twice daily for 6 weeks.

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Participants will receive placebo (a tablet that contains no active ingredient) to be taken twice daily for 6 weeks

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Treatment as Usual (TAU)
Description: subjects will receive a mood stabilizer per usual care
Study: NCT05605561

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Digital Story
Description: It is the standard of care given according to the hospital's policies and procedures.
Study: NCT06284434

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Liposomal Bupivacaine
Description: Patients will receive liposomal bupivacaine mixed with epinephrine (ratio of 1:100,000) for pain management after surgery.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Bupivacain
Description: Patients will receive standard bupivacaine mixed with epinephrine (ratio of 1:100,000) for pain management after surgery.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Epinephrine
Description: Patients will receive epinephrine (ratio of 1:100,000) mixed with the appropriate drug assigned to them based on their arm.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Epinephrine
Description: Patients will receive epinephrine (ratio of 1:100,000) mixed with the appropriate drug assigned to them based on their arm.
Study: NCT05247476

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: L-T4
Description: Patients with refractory hypothyroidism continued to receive L-T4 therapy. The drug dose was adjusted so that FT4 did not exceed the normal range, and the TSH suppression target was achieved as far as possible.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: L-T4+T3 (thyroid tablet)
Description: Patients with refractory hypothyroidism changed to receive L-T4 +T3 therapy. The drug dose was adjusted so that FT4 did not exceed the normal range, and the TSH suppression target was achieved as far as possible.
Study: NCT06229977

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Treatment as Usual (TAU)
Description: subjects will receive a mood stabilizer per usual care
Study: NCT05613075

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: tooth extraction and socket preservation with demineralized tooth graft
Description: tooth extraction and socket preservation with demineralized tooth graft
Study: NCT04875897

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: keepMED PAP device
Description: The keepMED PAP device is an automatic, wearable positive airway pressure device indicated for treatment of obstructive sleep apnea. A therapeutic pressure is delivered to the patient upper airway through a nasal interface. It is similar to other marketed positive airway pressure devices with respect to its fundamental use of positive airway pressure for the treatment of sleep apnea as well as with regard to its functional components and accessories (e.g., a PAP unit, a mask/nasal interface, an air filter, tubing, etc.).
Study: NCT04668703

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Conbercept intravitreal injection
Description: intravitreal injection of 0.5 mg conbercept at the conclusion of cataract surgery
Study: NCT06231563

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ketamine
Description: intravenous ketamine infusion 0.5 mg/kg

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Remimazolam
Description: intravenous remimazolam infusion 0.25 mg/kg
Study: NCT05613075

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: tooth extraction and socket preservation with demineralized tooth graft with hyaluronic acid
Description: tooth extraction and socket preservation with demineralized tooth graft with hyaluronic acid
Study: NCT05517733

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Platelet Rich Fibrin
Description: for the preparation of PRF, A well-trained professional nurse drew 10ml of patient blood from the antecubital vein and transferred it to a test tube without anticoagulant. The blood sample was immediately centrifuged for 10-12 minutes at 3000 rpm. L-PRF was ready to use after centrifugation.~PRF membrane was put over the implant and slightly tucked under the soft tissue periphery, then held in place with a figure-of-8 suture by 0.5 proline suture

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Diode laser
Description: * A 980 nm diode laser device (BIOLASE) was applied in a circular motion to the blood formed at the socket orifice at a power of 1W for 1 minute with a continuous wave mode, the application was done without touching the pooling blood and with a non-activated tip of the fiber optic.~* The laser application cycle was repeated 3-5 times to yield a stable fixed blood clot covering the dental implant with no oozing blood from its periphery.